Will a coronavirus vaccine be accessible to everyone or only the privileged few?
Article by Elena Kaniadakis on Euronews
“Twenty years have passed since the outbreak of SARS, yet the pharmaceutical industries haven’t considered infectious diseases a matter of priority because they are not as profitable as chronic diseases,” Massimo Florio, professor of public economics at the University of Milan, told Euronews. […]
Click here to read the article